[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Autologous Hematopoietic Stem Cell and/or Bone Marrow Transplantation after High Dose Chemotherapy (Carboplatinum, Etoposide) in Patients with Recurrent/Refractory Germ Cell Tumors.

What is the purpose of the study?

To provide autologous transplantation for patients with Germ Cell Tumors.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:

BMT 9401

Study Phase:


Patient Age Group:


Principal Investigator:

Dorothy C Pan, MD

Who is eligible?

Diagnosis of Germ Cell Tumors, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.

What is involved if I participate?

  • How long is the study?
    Inpatient stay approximately 21 days, followed for lifetime.
  • Is transportation provided or reimbursed?
  • Is parking provided or reimbursed?
  • What tests and procedures are involved?
    Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.

Where will the study take place?

SUNY Upstate Medical University,Syracuse, NY

Other Information:

Who can I contact for more information?

Name: Shramika Pokharel, MBBS, MPH
Phone: 315-464-8271
Email: pokhares@upstate.edu

Return to Previous Page || Search Again